Peer Review reports
From: Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab
| Original Submission | ||
|---|---|---|
| 10 Sep 2022 | Submitted | Original manuscript |
| 8 Jan 2023 | Reviewed | Reviewer Report |
| 16 Jan 2023 | Reviewed | Reviewer Report |
| 19 Mar 2023 | Author responded | Author comments - Xun Xu |
| 22 Mar 2023 | Author responded | Author comments - Xun Xu |
| Resubmission - Version 2 | ||
| 19 Mar 2023 | Submitted | Manuscript version 2 |
| 23 Mar 2023 | Author responded | Author comments - Xun Xu |
| Resubmission - Version 3 | ||
| 23 Mar 2023 | Submitted | Manuscript version 3 |
| 6 Apr 2023 | Reviewed | Reviewer Report |
| 8 Apr 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 8 Apr 2023 | Editorially accepted | |
| 26 Apr 2023 | Article published | 10.1186/s12886-023-02914-4 |
You can find further information about peer review here.